Tag Archives: GlobalPharma

Business & Investments

Globalpharma Inks 4 Strategic MoUs during ‘Make it in the Emirates 2025’ to Boost Pharma Localization and Innovation in the UAE

“These partnerships are enhancing the country’s position as a global hub for high-quality, future-ready healthcare solutions” – Dr. Thani Al Zeyoudi

Abu Dhabi, UAE – 22nd May 2025 – Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has signed 4 strategic Memorandums of Understanding (MoUs) during the Make it in the Emirates Forum 2025. The agreements reinforce the UAE’s position as a regional hub for pharmaceutical innovation, localization, and advanced healthcare manufacturing.

Continue reading Globalpharma Inks 4 Strategic MoUs during ‘Make it in the Emirates 2025’ to Boost Pharma Localization and Innovation in the UAE →
Business & Investments

Globalpharma Partners with ZIM Laboratories to Revolutionize Oral Drug Technology in the UAE

8th April, Dubai, UAE – Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has collaborated with India’s ZIM Laboratories to bring EU-certified Oral Dispersible Film (ODF) technology to its growing portfolio. This innovative drug technology has already received EU Good Manufacturing Practice (EU-GMP) certification, ensuring it meets the highest international quality and safety standards.

The agreement, unveiled at AIM Congress 2025 (7-9 April), underscores the UAE’s growing influence in global pharmaceutical innovation and its commitment to cutting-edge healthcare solutions.

Continue reading Globalpharma Partners with ZIM Laboratories to Revolutionize Oral Drug Technology in the UAE →
Business & Investments

GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia

Globalpharma’s sales in the Saudi pharmaceutical market surged by 139.5% year-over-year in May 2024, reaching $12.6M up from $5.2M in 2023

Dubai, UAE, 27 August 2024: Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, today announced a significant milestone by capturing a 1.8% market share in the competitive Saudi pharmaceutical landscape. As of May 2024, Globalpharma’s sales surged by 139.5% year-over-year, reaching $12.6 million up from $5.2 million in the same period last year.

Continue reading GlobalPharma captures 1.8% market share, marking unprecedented growth in Saudi Arabia →